ERIC DOBMEIER Insider Trading $ADPT Adaptive Biotechnologies Corp
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
Over the past year ERIC DOBMEIER has been an insider in 2 companies. The total value of shares held by ERIC DOBMEIER in these companies amounts to $240,800.
ERIC DOBMEIER ranks 27,847 out of 350,000 insiders. Go to Insider Ranking to see more.
ERIC DOBMEIER in Adaptive Biotechnologies CorpTrading Symbol: ADPT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) 
Position of ERIC DOBMEIER: Director
Holdings: 15,000 shares
Latest Transaction: Feb 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Last 3 Months Overview:
Shares Bought: 15,000
Shares Sold: 15,000
Share Difference: 0
Value Difference: +$344,551
Latest Insider Trading Transactions of ERIC DOBMEIER in Adaptive Biotechnologies Corp
|1 Week||2 Weeks||1 Month||3 Months||6 Months||1 Year||2 Years|
|No. of Purchases||0||0||0||1||1||1||1|
|Value of Purchases ($)||0||0||0||94,800||94,800||94,800||94,800|
|No. of Sales||0||0||0||2||2||2||2|
|Value of Sales ($)||0||0||0||439,351||439,351||439,351||439,351|
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Feb 18 2020||ADPT||Adaptive Biotechno ...||DOBMEIER ERIC||Director||Option Exercise||A||31.71||8,888||281,838||8,888|
|Dec 30 2019||ADPT||Adaptive Biotechno ...||DOBMEIER ERIC||Director||Option Exercise||M||6.32||15,000||94,800||85,000|
|Dec 30 2019||ADPT||Adaptive Biotechno ...||DOBMEIER ERIC||Director||Sell||D||29.91||2||60||0||2 to 0 (-100.00 %)|
|Dec 30 2019||ADPT||Adaptive Biotechno ...||DOBMEIER ERIC||Director||Sell||D||29.29||14,998||439,291||2||15 K to 2 (-99.99 %)|
|Dec 30 2019||ADPT||Adaptive Biotechno ...||DOBMEIER ERIC||Director||Buy||M||6.32||15,000||94,800||15,000||0 to 15 K|